UPADACITINIB (Rinvoq®)

Clinical Indication

Rheumatoid arthritis

Comments

In line with NICE TA665

Date of classification

February 2020

Red

Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.